Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

naltrexone hydrochloride/bupropion hydrochloride

A fixed combination of naltrexone hydrochloride, an opioid antagonist, and bupropion hydrochloride, an aminoketone antidepressant and a weak inhibitor of the neuronal reuptake of dopamine and norepinephrine, that may be used for appetite regulation, weight management and weight loss. Upon oral administration of naltrexone hydrochloride/bupropion hydrochloride, naltrexone binds to and blocks the various opioid receptors in the central nervous system. Bupropion inhibits neuronal reuptake of dopamine and norepinephrine, thereby increasing the level of these neurotransmitters. Bupropion may also have a direct effect on the hypothalamus, the appetite regulatory center. These actions may block the rewarding aspects of food and reduce appetite and food cravings, and contribute to weight loss.
Synonym:bupropion hydrochloride-naltrexone hydrochloride
US brand name:Contrave
Search NCI's Drug Dictionary